AANP: Vaccination Against Pneumonia Should Be a Patient-Education Focus

Community Acquired Pneumonia (CAP) is the sixth leading cause of death in the U.S., yet health care professionals don't always offer immunization to their most vulnerable patients.

Action Points

Explain to patients ages 65 and...

Two Firms Launch Competing Versions of Generic Adoxa

Bradley Pharmaceuticals launched an authorized generic version of 150-mg Adoxa tablets after the FDA recently approved Mylan Pharmaceuticals’ generic version of the antibiotic.

Under Bradley’s licensing and distribution...

Ranbaxy receives approval to market doxycycline tablets

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL has received approval from the U.S. Food & Drug Administration (FDA) to manufacture and market doxycycline...

Teaching Old Mice New Tricks Opens Door to Lost Memories

Mice with induced brain atrophy that were exposed to new toys and playmates in an "enriched environment" were able to build new pathways to faded memories.

The research by Li-Huei Tsai, Ph.D., of Massachusetts Institute of...

Resistance Takes Gonorrhea to Last Line of Defense

The rate of fluoroquinolone-resistant gonorrhea has become so high in the U.S. that physicians have been urged to switch to the last line of defense, the cephalosporins.

Resistance to fluoroquinolones such as ciprofloxacin...